JP2025500860A - ｄｓＲＮＡ、その調製方法及び使用 - Google Patents

ｄｓＲＮＡ、その調製方法及び使用 Download PDF

Info

Publication number
JP2025500860A
JP2025500860A JP2024535520A JP2024535520A JP2025500860A JP 2025500860 A JP2025500860 A JP 2025500860A JP 2024535520 A JP2024535520 A JP 2024535520A JP 2024535520 A JP2024535520 A JP 2024535520A JP 2025500860 A JP2025500860 A JP 2025500860A
Authority
JP
Japan
Prior art keywords
seq
dsrna
antisense strand
group
sense strand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024535520A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025500860A5 (https=
Inventor
云▲飛▼ 李
▲ジェン▼ ▲張▼
哲 侯
俊 耿
建羽 ▲張▼
雅琴 周
▲龍▼▲飛▼ 黄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tuojie Biotech Shanghai Co Ltd
Original Assignee
Tuojie Biotech Shanghai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tuojie Biotech Shanghai Co Ltd filed Critical Tuojie Biotech Shanghai Co Ltd
Publication of JP2025500860A publication Critical patent/JP2025500860A/ja
Publication of JP2025500860A5 publication Critical patent/JP2025500860A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2024535520A 2021-12-16 2022-12-16 ｄｓＲＮＡ、その調製方法及び使用 Pending JP2025500860A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202111542797.4 2021-12-16
CN202111542797 2021-12-16
PCT/CN2022/139488 WO2023109938A1 (zh) 2021-12-16 2022-12-16 一种dsRNA、其制备方法及应用

Publications (2)

Publication Number Publication Date
JP2025500860A true JP2025500860A (ja) 2025-01-15
JP2025500860A5 JP2025500860A5 (https=) 2025-12-26

Family

ID=86774893

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024535520A Pending JP2025500860A (ja) 2021-12-16 2022-12-16 ｄｓＲＮＡ、その調製方法及び使用

Country Status (6)

Country Link
JP (1) JP2025500860A (https=)
KR (1) KR20240116537A (https=)
CN (1) CN118302526A (https=)
CA (1) CA3240651A1 (https=)
TW (1) TW202334425A (https=)
WO (1) WO2023109938A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024125636A1 (zh) * 2022-12-16 2024-06-20 上海拓界生物医药科技有限公司 Toll样受体调节剂与dsRNA的联合治疗
CN119816597A (zh) * 2023-08-10 2025-04-11 石药集团中奇制药技术（石家庄）有限公司 一种抑制HBV基因表达的dsRNA分子及其应用
CN116854754B (zh) 2023-09-01 2023-12-12 北京悦康科创医药科技股份有限公司 一种含有核糖环或其衍生结构的GalNAc化合物及其寡核苷酸缀合物
CN118638166B (zh) 2024-08-15 2024-12-17 北京悦康科创医药科技股份有限公司 含有三氮唑结构的GalNAc化合物及其寡核苷酸缀合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101773551B1 (ko) * 2008-10-15 2017-08-31 아이오니스 파마수티컬즈, 인코포레이티드 인자 １１ 발현의 조정
EA024762B9 (ru) * 2011-06-30 2017-04-28 Эрроухэд Рисерч Корпорейшн Композиции и способы ингибирования экспрессии генов вируса гепатита в
EP3719127A4 (en) * 2017-12-01 2021-10-20 Suzhou Ribo Life Science Co., Ltd. NUCLEIC ACID, COMPOSITION AND CONJUGATE WITH IT, MANUFACTURING METHOD AND USE
CN111378655B (zh) * 2018-12-28 2024-03-19 苏州瑞博生物技术股份有限公司 抑制CTGF基因表达的siRNA、含有该siRNA的药物组合物及其用途
AU2020280439B2 (en) * 2019-05-22 2025-08-14 Suzhou Ribo Life Science Co., Ltd. Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use
KR20220011689A (ko) * 2019-05-22 2022-01-28 쑤저우 리보 라이프 사이언스 컴퍼니, 리미티드 핵산, 약제학적 조성물, 접합체, 제조 방법, 및 용도

Also Published As

Publication number Publication date
CN118302526A (zh) 2024-07-05
CA3240651A1 (en) 2023-06-22
KR20240116537A (ko) 2024-07-29
WO2023109938A1 (zh) 2023-06-22
TW202334425A (zh) 2023-09-01

Similar Documents

Publication Publication Date Title
JP7849353B2 (ja) オフターゲット活性が低減された修飾ｓｉＲＮＡ
JP2025500860A (ja) ｄｓＲＮＡ、その調製方法及び使用
TW202340466A (zh) 一種ｄｓｒｎａ、其製備方法及應用
JP2024541713A (ja) アンジオテンシノーゲンを標的とするｓｉＲＮＡ及びその医薬的使用
WO2023208023A1 (zh) 氘代化学修饰和包含其的寡核苷酸
JP2024515194A (ja) １７β－ヒドロキシステロイドデヒドロゲナーゼの１３型を標的とするｓｉＲＮＡ及びｓｉＲＮＡ複合体
JP2024545222A (ja) ＬＰＡを標的とするｓｉＲＮＡ及び複合体
TW202302851A (zh) Ｂ型肝炎病毒ｓｉＲＮＡ和ｓｉＲＮＡ綴合物
TW202334424A (zh) 一種ｄｓｒｎａ、其製備方法及應用
JP2025504845A (ja) ｄｓＲＮＡ、その使用及び調製方法
TW202339773A (zh) 一種ｄｓＲＮＡ、其應用及製備方法
RU2849194C1 (ru) МОДИФИЦИРОВАННАЯ миРНК С ПОНИЖЕННОЙ НЕЦЕЛЕВОЙ АКТИВНОСТЬЮ
WO2024125636A1 (zh) Toll样受体调节剂与dsRNA的联合治疗
EA052687B1 (ru) дцРНК, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И ЕЕ ПРИМЕНЕНИЕ
WO2026086824A1 (zh) 双链寡核苷酸、缀合物和组合物以及它们的用途
CN120209036A (zh) 一种新型的化合物及其用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251216

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251216